US Medicare says Part D and Advantage premiums will fall in 2025
The House of Representatives unanimously passed the Seniors’ Access to Critical Medications Act (HR 5526) on Monday, moving the bipartisan bill onto the Senate.1
The Medicare Advantage Influence Machine
The House of Representatives unanimously passed the Seniors’ Access to Critical Medications Act (HR 5526) on Monday, moving the bipartisan bill onto the Senate.1
House Unanimously Passes Seniors’ Access to Critical Medications Act
The House of Representatives unanimously passed the Seniors’ Access to Critical Medications Act (HR 5526) on Monday, moving the bipartisan bill onto the Senate.1
Cancer and Diabetes Drugs Expected to Dominate 2025 Medicare Negotiations Under IRA
Many Big Pharma companies including Pfizer, Merck and BMS make the drugs that some researchers expect to be selected by CMS for next year’s Medicare price negotiations alongside analysts’ top pick, Novo Nordisk’s Ozempic.
Doctors Organize to Push Back Against Private-Equity Takeovers
Private equity’s takeover of thousands of healthcare businesses has sparked a backlash among physicians, and many are joining new professional organizations to oppose corporate influence in U.S. medicine.
An Overland Park pharmacist quit the drug insurance game. He says it could save you money
The prescription insurance industry — and particularly PBMs, the powerful middlemen at its heart — get blamed for pharmacies closing down and patients often paying too much for medicine. Regulators are looking at what to do about it.
Hospitals on defense as Congress weighs pay, 340B, M&A bills
With an election fast approaching and a consequential healthcare package forming in Congress, hospitals are finding themselves in the unusual position of playing defense.
House Passes Rep. Harshbarger’s H.R. 5526, The Seniors’ Access to Critical Medications Act
Hospital groups are calling for the federal government to take action after Johnson & Johnson warned it will require 340B-eligible providers to pay full price up front for two widely prescribed medications and seek legally required discounts later.
Shutdown showdown yields to bipartisan compromise — of sorts
Hospital groups are calling for the federal government to take action after Johnson & Johnson warned it will require 340B-eligible providers to pay full price up front for two widely prescribed medications and seek legally required discounts later.
Physicians could lose $25B with new CMS policy: Study
Hospital groups are calling for the federal government to take action after Johnson & Johnson warned it will require 340B-eligible providers to pay full price up front for two widely prescribed medications and seek legally required discounts later.
